CMS-Manufacturer Discussion Of Medicare Price Negotiation Program Scheduled For 13 December
Executive Summary
Agency reaches out to manufacturers as it develops its approach to implementing the controversial new program.
You may also be interested in...
CMS Building Rx Price Negotiating Staff Internally; Contracting With Outside Groups ‘Not On Radar’
CMS head Brooks-LaSure says agency is making progress in staffing the drug pricing control programs established by the Inflation Reduction Act. Medicare Center deputy director Cheri Rice will be its acting director under just-unveiled management structure.
Medicare Drug Price Control Group Formed At CMS: How Will Stakeholders Interact?
As the Centers for Medicare and Medicaid Services begins the process of building new price negotiation and inflation rebate programs within Medicare, stakeholders are watching to see how transparent the process will be and how much outside input the agency will seek.
Medicare Price ‘Negotiation’ Process Gets Broad Brush Treatment In New Law
With enactment of the drug pricing reform provisions in the Inflation Reduction Act, stakeholders now turn their attention to the implementing regulations that will be developed by the Centers for Medicare and Medicaid Services.